ATE414905T1 - Diabetesmodell - Google Patents

Diabetesmodell

Info

Publication number
ATE414905T1
ATE414905T1 AT02775020T AT02775020T ATE414905T1 AT E414905 T1 ATE414905 T1 AT E414905T1 AT 02775020 T AT02775020 T AT 02775020T AT 02775020 T AT02775020 T AT 02775020T AT E414905 T1 ATE414905 T1 AT E414905T1
Authority
AT
Austria
Prior art keywords
ljungan virus
nucleic acid
disclosed
isolated nucleic
nucleotide sequence
Prior art date
Application number
AT02775020T
Other languages
English (en)
Inventor
Bo Niklasson
Ake Lernmark
Original Assignee
Apodemus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apodemus Ab filed Critical Apodemus Ab
Application granted granted Critical
Publication of ATE414905T1 publication Critical patent/ATE414905T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/085Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
AT02775020T 2001-08-22 2002-08-21 Diabetesmodell ATE414905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0120437.9A GB0120437D0 (en) 2001-08-22 2001-08-22 Diabetic model

Publications (1)

Publication Number Publication Date
ATE414905T1 true ATE414905T1 (de) 2008-12-15

Family

ID=9920833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02775020T ATE414905T1 (de) 2001-08-22 2002-08-21 Diabetesmodell

Country Status (7)

Country Link
US (2) US7560609B2 (de)
EP (1) EP1432990B1 (de)
AT (1) ATE414905T1 (de)
AU (1) AU2002341238A1 (de)
DE (1) DE60229966D1 (de)
GB (1) GB0120437D0 (de)
WO (1) WO2003019197A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073710A1 (en) * 2003-02-21 2004-09-02 Apodemus Ab Treatment of diseases caused by ljungan virus by using pleconaril
GB0505321D0 (en) * 2005-03-15 2005-04-20 Apodemus Ab Detection method
EP1743522A1 (de) * 2005-07-13 2007-01-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Tiermodelle für Typ-II Diabetes und X-Syndrom
WO2007133189A2 (en) * 2006-05-01 2007-11-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services,Centers For Disease Control And Prevention Methods and agents for detecting parechovirus
EP2788477A2 (de) * 2011-12-07 2014-10-15 Institut Pasteur Identifizierung des porcinen parecho-like virus und anwendungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603305D0 (sv) * 1996-09-11 1996-09-11 Bo Niklasson New picornaviruses, vaccines and diagnostic kits

Also Published As

Publication number Publication date
US20040265793A1 (en) 2004-12-30
DE60229966D1 (de) 2009-01-02
US20120027776A1 (en) 2012-02-02
AU2002341238A1 (en) 2003-03-10
EP1432990B1 (de) 2008-11-19
WO2003019197A3 (en) 2004-05-06
EP1432990A2 (de) 2004-06-30
US7560609B2 (en) 2009-07-14
GB0120437D0 (en) 2001-10-17
WO2003019197A2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
NO20042570L (no) Antimikrobielle polypeptider fra Pseudoplectania nigrella
ATE398179T1 (de) Von rna polymerasen abstammende polypeptide und ihre verwendungen
NO20043419L (no) Nytt cytokin, zcytor17-ligand
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1124846T3 (da) Nukleotid- og proteinsekvenser af Nogo-gener og derpå baserede fremgangsmåder
DE602006020032D1 (de) Il-21-varianten
DK1129190T3 (da) Human TSLP DNA og polypeptider
EP1652923A4 (de) Bei krebs überexprimiertes gen
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
TR200401186T4 (tr) Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları.
ATE501258T1 (de) Lawsonia intracellularis impfstoff
DE502004011932D1 (de) Verfahren zur herstellung von 3-methylamino-1-(thien-2-yl)-propan-1-ol
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
ATE321853T1 (de) Humanische pellino-polypeptide
DE60229966D1 (de) Diabetesmodell
NO20005608D0 (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
DK1383796T3 (da) Neurovirulent stamme af viruset West Nile og anvendelser heraf
SE0102198D0 (sv) New sequences
WO2002083727A3 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
EP1568775A4 (de) Krebs-assoziiertes gen
EP1584628A3 (de) Virusprotein
ATE391137T1 (de) G-protein gekoppelter rezeptor
EA200400534A1 (ru) Стимуляция тимозином генетической иммунизации

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties